The second progress report on the Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study.

What Was Tested

Researchers studied Angiotensin II Type 1 Receptor Blockers in the context of low blood pressure and orthostatic hypotension in this randomized controlled trial publication.

The Hypertension Objective treatment based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) study is a large-scale intervention trial to determine both optimal target blood pressure (BP) on the basis of self-measured BP at home, and optimal initial antihypertensive medication.

To investigate the quality of randomization at the end of March 2003, and BP-controlled conditions during initial 6 months.

Who Took Part

The researchers evaluated the number of patients randomized by the end of March 2003, and BP changes during the initial 6 months based on intention-to-treat analysis.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Angiotensin II Type 1 Receptor Blockers study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The subject headings attached to it are Angiotensin II Type 1 Receptor Blockers, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Blood Pressure Determination, Calcium Channel Blockers, Clinical Protocols and Hypertension.

What This Means in Plain Language

The paper is a randomized study of Angiotensin II Type 1 Receptor Blockers in people with low blood pressure and orthostatic hypotension.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2004 (Blood pressure monitoring), a journal based in England.

More context: Low blood pressure and orthostatic hypotension research.